Atra stock forecast.

allforecast.com

Atra stock forecast. Things To Know About Atra stock forecast.

4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price.Rivian Automotive Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 18.63. Negative dynamics for Rivian Automotive shares will prevail with possible volatility of 5.691%. Pessimistic target level: 18.06. Optimistic target level: 19.15.Find the latest Atlas Lithium Corporation (ATLX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Aug 21, 2023 · ATRA stock forecast Our latest prediction for Atara Biotherapeutics Inc's stock price was made on the Aug. 21, 2023 when the stock price was at 1.41$. In the short term (2weeks), ATRA's stock price should underperform the market by -2.71%. During that period the price should oscillate between -13.09% and +13.51%.

3 Wall Street analysts have issued 1-year price objectives for Aurora Innovation's stock. Their AUR share price targets range from $1.75 to $7.00. On average, they anticipate the company's share price to reach $3.94 in the next twelve months. This suggests a possible upside of 79.8% from the stock's current price.The MannKind Corporation stock price gained 5.56% on the last trading day (Friday, 17th Nov 2023), rising from $3.60 to $3.80. During the last trading day the stock fluctuated 6.06% from a day low at $3.63 to a day high of $3.85. The price has been going up and down for this period, and there has been a -4.04% loss for the last 2 weeks.

Oct 9, 2023 · Atara Biotherapeutics stock forecast for Apr 2025. Estimated Average Forecasted Atara Biotherapeutics Price: 1.93. Positive monthly dynamics of the instrument is expected with 6.030% volatility is expected. Pessimistic forecast: 1.88. Optimistic: 2.00. Atara Biotherapeutics stock forecast for May 2025. 10 equities research analysts have issued 1-year price objectives for Walgreens Boots Alliance's stock. Their WBA share price targets range from $21.00 to $45.00. On average, they anticipate the company's stock price to reach $29.36 in the next year. This suggests a possible upside of 41.2% from the stock's current price.

Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Stock Price Forecast. The 15 analysts offering 12-month price forecasts for Rolls-Royce Holdings PLC have a median target of 10.14, with a high estimate of 15.24 and a low estimate of 3.58. The ...Atara Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ATRA updated stock price target summary. UNG Signals & Forecast. There are few to no technical positive signals at the moment. The United States Natural Gas Fund, LP ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term …

4 ago 2022 ... " Stock price fell from $12.85 per share to $10.21 per share the next trading day, as the market reacted negatively to this prediction. On ...

Get the latest Atara Biotherapeutics Inc (ATRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Aug 8, 2023 · Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -4.62% and 71.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? LVTX Stock 12 Months Forecast. $6.00. (354.55% Upside) Based on 3 Wall Street analysts offering 12 month price targets for LAVA Therapeutics in the last 3 months. The average price target is $6.00 with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 354.55% change from the last price of $1.32.Atara Biotherapeutics stock price predictions for 2023, 2024, 2025, 2026, 2027 using artificial intelligence. How much will Atara Biotherapeutics cost in 2021-2025?Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period.

Find real-time ATRA - Atara Biotherapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Atara Biotherapeutics Stock Forecast, "ATRA" Share Price Prediction Charts Is "Atara Biotherapeutics Inc" a Good Investment? Current price today: 0.650 USD (+2.331%) …On November 2, 2023, Atara Biotherapeutics Inc (ATRA) experienced a significant surge in its stock performance following positive price forecasts from analysts. According to data from CNN Money, seven analysts have offered 12-month price forecasts for ATRA, with a median target of $19.00.Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.Neos Therapeutics, Inc. (NASDAQ:NEOS) posted its quarterly earnings results on Monday, November, 9th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.05. The firm earned $12.54 million during the quarter.

1 Wall Street analysts have issued twelve-month price objectives for ARMOUR Residential REIT's shares. Their ARR share price targets range from $20.00 to $25.00. On average, they anticipate the company's share price to reach $22.50 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.

NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.3 Wall Street research analysts have issued 12 month price targets for Invesco Mortgage Capital's stock. Their IVR share price targets range from $10.50 to $11.00. On average, they expect the company's stock price to reach $10.75 in the next year. This suggests a possible upside of 31.0% from the stock's current price.The Fly Atara Biotherapeutics downgraded to In Line from Outperform ... The Fly Atara Biotherapeutics price target lowered to $13 from $19 a... The Fly Atara Biotherapeutics downgraded to Neutral from Buy at H.C.... The Fly Atara Biotherapeutics downgraded to Neutral from Buy at Mizu... The Fly Atara Biotherapeutics’ ATA188 did not meet ...Mullen Automotive Stock Forecast. Stock Price Forecast. There is currently no analyst price target forecast available for MULN stock. Analyst Consensus: n/a. Target Low Average Median High; Price: n/a: n/a: n/a: n/a: Change: n/a: n/a: n/a: n/a: Analyst Ratings. There are currently no analyst ratings available for MULN. Recommendation …Google stock prediction on Friday, December, 29: 137 dollars, maximum 148, minimum 126. In 4 weeks Google stock price forecast on Monday, January, 1: 139 dollars, maximum 150, minimum 128. Google stock prediction on Tuesday, January, 2: 140 dollars, maximum 151, minimum 129. The forecast is updated on daily basis.Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.Atara Biotherapeutics, Inc. (Ticker: ATRA) closed the trading day on December 1, 2023, with a slight decline of 1.85%, ending the session at $0.65. The stock traded within a range of $0.57 to $0.65 on the same day, indicating a degree of volatility. ... the stock's technical outlook and negative profitability metrics pose considerable risks for ...16 sept 2020 ... See if the stock goes on to build a promising consolidation that could kick off a new price move. Atara Biotherapeutics (ATRA).

The average Li Cycle Holdings stock price prediction forecasts a potential upside of 484.05% from the current LICY share price of $0.70. What is LICY's forecast return on equity (ROE) for 2023-2025? (NYSE: LICY) forecast ROE is …

On November 2, 2023, Atara Biotherapeutics Inc (ATRA) experienced a significant surge in its stock performance following positive price forecasts from analysts. According to data from CNN Money, seven analysts have offered 12-month price forecasts for ATRA, with a median target of $19.00.

Aug 8, 2023 · Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -4.62% and 71.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? ATRA stock had an impressive performance on September 26, 2023, with the potential for significant growth in the coming months. According to CNN Money, seven analysts have provided 12-month price forecasts for Atara Biotherapeutics Inc, with a median target of $20.00.25 abr 2023 ... Atrás. Cuenta de Cloud Iniciar sesión en ... Proper inventory management involves active monitoring of stocks, the use of technology to forecast ...Orchid Island Capital (NYSE:ORC) pays an annual dividend of $1.44 per share and currently has a dividend yield of 19.54%. ORC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ORC.ATRA | Atara Biotherapeutics, Inc. Healthcare NASDAQ 📈 Technical Chart Patterns & Trend Analysis 📉 Identifying potential trading opportunities based on trend analysis: bullish divergence can be seen oh daily time frame and aslo a double bottom indicating a trend reversal. BUY STOP will be good option in this scenario . 📊 Technical analysis helps id 📈 …Find real-time PLTR - Palantir Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 27, 2023 · Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (2.683 $). This rich reservoir of information aids in informed decision-making, blending historical data with future predictions to paint a holistic picture of stock performance trajectories. …Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -4.62% and 71.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?16 analysts have issued twelve-month price objectives for Alibaba Group's shares. Their BABA share price targets range from $90.00 to $150.00. On average, they expect the company's share price to reach $129.20 in the next year. This suggests a possible upside of 74.6% from the stock's current price.

NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.What's Happening With Atara Biotherapeutics Inc Stock Today? Atara Biotherapeutics Inc (ATRA) stock is trading at $0.65 as of 1:00 PM on Friday, Nov 24, a gain of $0.08, or 13.93% from the previous closing price of $0.57. The stock has traded between $0.55 and $0.72 so far today. Volume today is 7,132,201 compared to average volume of 6,444,546.THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl... 4 days ago - Business Wire Atara Biotherapeutics To Participate at the Stifel Healthcare ConferenceInstagram:https://instagram. mindful trader reviewsforex mt4 brokersstocks for under dollar10vertical farming stocks 8 brokers have issued 12-month target prices for Cresco Labs' stock. Their CRLBF share price targets range from $2.50 to $34.00. On average, they predict the company's stock price to reach $16.05 in the next twelve months. This suggests a possible upside of 833.1% from the stock's current price. View analysts price targets for CRLBF … platform for futures tradingstock options training Oncology Pharma's stock was trading at $0.3386 at the beginning of the year. Since then, ONPH shares have decreased by 99.9% and is now trading at $0.0002. View the best growth stocks for 2023 here.4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price. lucid futures Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Find real-time ATRA - Atara Biotherapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.